Joyce J. Lee - Net Worth and Insider Trading

Joyce J. Lee Net Worth

The estimated net worth of Joyce J. Lee is at least $347,920 dollars as of 2024-11-13. Joyce J. Lee is the Executive Vice President of Zoetis Inc and owns about 2,000 shares of Zoetis Inc (ZTS) stock worth over $347,920. Details can be seen in Joyce J. Lee's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joyce J. Lee has not made any transactions after 2013-02-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Joyce J. Lee

Joyce J. Lee Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joyce J. Lee owns 3 companies in total, including Elanco Animal Health Inc (ELAN) , Balchem Corp (BCPC) , and Zoetis Inc (ZTS) .

Click here to see the complete history of Joyce J. Lee’s form 4 insider trades.

Insider Ownership Summary of Joyce J. Lee

Ticker	Comapny	Transaction Date	Type of Owner
ELAN	Elanco Animal Health Inc	2020-08-01	Ex VP & Prs US Pet Hlth Com Op
BCPC	Balchem Corp	2019-09-12	director
ZTS	Zoetis Inc	2013-08-15	Executive Vice President

Joyce J. Lee Latest Holdings Summary

Joyce J. Lee currently owns a total of 1 stock. Joyce J. Lee owns 2,000 shares of Zoetis Inc (ZTS) as of February 6, 2013, with a value of $347,920.

Latest Holdings of Joyce J. Lee

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ZTS	Zoetis Inc	2013-02-06	2,000	173.96	347,920

Holding Weightings of Joyce J. Lee

Joyce J. Lee Form 4 Trading Tracker

According to the SEC Form 4 filings, Joyce J. Lee has made a total of 0 transactions in Zoetis Inc (ZTS) over the past 5 years. The most-recent trade in Zoetis Inc is the acquisition of 2,000 shares on February 6, 2013, which cost Joyce J. Lee around $52,000.

Insider Trading History of Joyce J. Lee

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joyce J. Lee Trading Performance

GuruFocus tracks the stock performance after each of Joyce J. Lee's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joyce J. Lee is 6.16%. GuruFocus also compares Joyce J. Lee's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joyce J. Lee within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Joyce J. Lee's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Joyce J. Lee

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	9.09
Relative Return to S&P 500(%)	7.15

Joyce J. Lee Ownership Network

Ownership Network List of Joyce J. Lee

No Data

Ownership Network Relation of Joyce J. Lee

Joyce J. Lee Owned Company Details

What does Elanco Animal Health Inc do?

Who are the key executives at Elanco Animal Health Inc?

Joyce J. Lee is the Ex VP & Prs US Pet Hlth Com Op of Elanco Animal Health Inc. Other key executives at Elanco Animal Health Inc include director & Pres. & Chief Executive Officer Jeffrey N Simmons , EVP & MANUFACTURING AND QUALITY Grace Mcardle , and See remarks Timothy J Bettington .

Elanco Animal Health Inc (ELAN) Insider Trades Summary

Over the past 18 months, Joyce J. Lee made no insider transaction in Elanco Animal Health Inc (ELAN). Other recent insider transactions involving Elanco Animal Health Inc (ELAN) include a net purchase of 30,000 shares made by William F Doyle , a net purchase of 6,600 shares made by Michael J Harrington , and a net purchase of 100,000 shares made by Jeffrey N Simmons .

In summary, during the past 3 months, insiders sold 0 shares of Elanco Animal Health Inc (ELAN) in total and bought 3,500 shares, with a net purchase of 3,500 shares. During the past 18 months, 0 shares of Elanco Animal Health Inc (ELAN) were sold and 156,600 shares were bought by its insiders, resulting in a net purchase of 156,600 shares.

Elanco Animal Health Inc (ELAN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Elanco Animal Health Inc Insider Transactions

No Available Data

What does Balchem Corp do?

Who are the key executives at Balchem Corp?

Joyce J. Lee is the director of Balchem Corp. Other key executives at Balchem Corp include Vice President Van Gunsteren Job Leonard , Chief Accounting Officer William A. Backus , and Chief Technology Officer Michael Robert Sestrick .

Balchem Corp (BCPC) Insider Trades Summary

Over the past 18 months, Joyce J. Lee made no insider transaction in Balchem Corp (BCPC). Other recent insider transactions involving Balchem Corp (BCPC) include a net sale of 35,984 shares made by William A. Backus , a net sale of 13,029 shares made by Michael Robert Sestrick , and a net sale of 8,800 shares made by David B Fischer .

In summary, during the past 3 months, insiders sold 0 shares of Balchem Corp (BCPC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 136,264 shares of Balchem Corp (BCPC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 136,264 shares.

Balchem Corp (BCPC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Balchem Corp Insider Transactions

No Available Data

What does Zoetis Inc do?

Who are the key executives at Zoetis Inc?

Joyce J. Lee is the Executive Vice President of Zoetis Inc. Other key executives at Zoetis Inc include Executive Vice President Roxanne Lagano , Executive Vice President Kristin C Peck , and Executive Vice President Heidi C. Chen .

Zoetis Inc (ZTS) Insider Trades Summary

Over the past 18 months, Joyce J. Lee made no insider transaction in Zoetis Inc (ZTS). Other recent insider transactions involving Zoetis Inc (ZTS) include a net sale of 14,018 shares made by Roxanne Lagano , a net sale of 52,000 shares made by Kristin C Peck , and a net sale of 9,905 shares made by Heidi C. Chen .

In summary, during the past 3 months, insiders sold 0 shares of Zoetis Inc (ZTS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 78,472 shares of Zoetis Inc (ZTS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 78,472 shares.

Zoetis Inc (ZTS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Zoetis Inc Insider Transactions

No Available Data

Joyce J. Lee Mailing Address

Above is the net worth, insider trading, and ownership report for Joyce J. Lee. You might contact Joyce J. Lee via mailing address: C/o Zoetis Inc., 100 Campus Drive, Florham Park Nj 07940.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.